Cargando…

Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy

Nanoparticles have unique properties and high design flexibility, which are thought to be safe, site-specific, and efficient drug delivery systems. However, nanoparticles as exogenous materials can provide recognition and be eliminated by the body’s immune system, which considerably restricts their...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xuefen, Yan, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941025/
https://www.ncbi.nlm.nih.gov/pubmed/35316443
http://dx.doi.org/10.1186/s11671-022-03673-9
_version_ 1784673021969039360
author Zhao, Xuefen
Yan, Chao
author_facet Zhao, Xuefen
Yan, Chao
author_sort Zhao, Xuefen
collection PubMed
description Nanoparticles have unique properties and high design flexibility, which are thought to be safe, site-specific, and efficient drug delivery systems. However, nanoparticles as exogenous materials can provide recognition and be eliminated by the body’s immune system, which considerably restricts their applications. To overcome these drawbacks, natural cell membrane coating method has attracted great attention in the field of drug delivery systems, which can prolong nanoparticles blood circulation time and avoiding the capture as well as elimination by the body immune system. Biomimetic nanoparticles via a top-down approach can avoid the laborious group modified engineering and keep the integrity of cell membrane structure and membrane antigens, which can be endowed with unique properties, such as immune escape, longer blood circulation time, targeting delivery and controlling drugs sustain-release. At the present research, erythrocyte membrane, cancer cell membrane, platelet membrane, lymphocyte membrane and hybrid membrane have been successfully coated into the surface of nanoparticles to achieve biological camouflage. Thus, integrating various kinds of cell membranes and nanoparticles into one system, the biomimetic nanoparticles can inherit unique biofunction and drug delivery properties to exhibit tumor targeting-delivery and antitumor outcomes. In this article, we will discuss the prospects and challenges of some basic cell membrane cloaking nanoparticles as a drug delivery system for cancer therapy.
format Online
Article
Text
id pubmed-8941025
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-89410252022-04-08 Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy Zhao, Xuefen Yan, Chao Nanoscale Res Lett Nano Review Nanoparticles have unique properties and high design flexibility, which are thought to be safe, site-specific, and efficient drug delivery systems. However, nanoparticles as exogenous materials can provide recognition and be eliminated by the body’s immune system, which considerably restricts their applications. To overcome these drawbacks, natural cell membrane coating method has attracted great attention in the field of drug delivery systems, which can prolong nanoparticles blood circulation time and avoiding the capture as well as elimination by the body immune system. Biomimetic nanoparticles via a top-down approach can avoid the laborious group modified engineering and keep the integrity of cell membrane structure and membrane antigens, which can be endowed with unique properties, such as immune escape, longer blood circulation time, targeting delivery and controlling drugs sustain-release. At the present research, erythrocyte membrane, cancer cell membrane, platelet membrane, lymphocyte membrane and hybrid membrane have been successfully coated into the surface of nanoparticles to achieve biological camouflage. Thus, integrating various kinds of cell membranes and nanoparticles into one system, the biomimetic nanoparticles can inherit unique biofunction and drug delivery properties to exhibit tumor targeting-delivery and antitumor outcomes. In this article, we will discuss the prospects and challenges of some basic cell membrane cloaking nanoparticles as a drug delivery system for cancer therapy. Springer US 2022-03-22 /pmc/articles/PMC8941025/ /pubmed/35316443 http://dx.doi.org/10.1186/s11671-022-03673-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Nano Review
Zhao, Xuefen
Yan, Chao
Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy
title Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy
title_full Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy
title_fullStr Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy
title_full_unstemmed Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy
title_short Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy
title_sort research progress of cell membrane biomimetic nanoparticles for tumor therapy
topic Nano Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941025/
https://www.ncbi.nlm.nih.gov/pubmed/35316443
http://dx.doi.org/10.1186/s11671-022-03673-9
work_keys_str_mv AT zhaoxuefen researchprogressofcellmembranebiomimeticnanoparticlesfortumortherapy
AT yanchao researchprogressofcellmembranebiomimeticnanoparticlesfortumortherapy